Nuvalent said its drug for ALK+ lung cancer shrank tumors in more than a quarter of patients whose disease had returned after ...

WuXi AppTec, the Chinese pharma giant with extensive ties with U.S. companies, appears to be thriving now that the threat of ...

ROAI isn't about flashy demos or model size. It's about measurable improvements,” writes Sanofi CEO Paul Hudson.

We both lost our jobs as public health diplomats with the U.S. Agency for International Development last summer. Our termination from federal service also meant that both of us lo ...